BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 25656989)

  • 21. Immuno-Oncology Biomarkers for Gastric and Gastroesophageal Junction Adenocarcinoma: Why PD-L1 Testing May Not Be Enough.
    Weinberg BA; Xiu J; Hwang JJ; Shields AF; Salem ME; Marshall JL
    Oncologist; 2018 Oct; 23(10):1171-1177. PubMed ID: 29703766
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Factors predicting survival in patients with proximal gastric carcinoma involving the esophagus.
    Zhang YF; Shi J; Yu HP; Feng AN; Fan XS; Lauwers GY; Mashimo H; Gold JS; Chen G; Huang Q
    World J Gastroenterol; 2012 Jul; 18(27):3602-9. PubMed ID: 22826627
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HER2/neu gene amplification and protein overexpression in gastric and gastroesophageal junction adenocarcinoma: a review of histopathology, diagnostic testing, and clinical implications.
    Hechtman JF; Polydorides AD
    Arch Pathol Lab Med; 2012 Jun; 136(6):691-7. PubMed ID: 22646280
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MAGEA10 expression is a predictive marker of early hepatic recurrence after curative gastrectomy for gastric and gastroesophageal junction cancer.
    Fujiya K; Terashima M; Ohshima K; Aizawa D; Sugino T; Serizawa M; Nakamura K; Nagashima T; Hatakeyama K; Urakami K; Akiyama Y; Tsubosa Y; Kitagawa Y; Yamaguchi K
    Gastric Cancer; 2021 Mar; 24(2):341-351. PubMed ID: 32965606
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identical cytokeratin expression pattern CK7+/CK20- in esophageal and cardiac cancer: etiopathological and clinical implications.
    Driessen A; Nafteux P; Lerut T; Van Raemdonck D; De Leyn P; Filez L; Penninckx F; Geboes K; Ectors N
    Mod Pathol; 2004 Jan; 17(1):49-55. PubMed ID: 14631371
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association between HSP90 and Her2 in gastric and gastroesophageal carcinomas.
    Berezowska S; Novotny A; Bauer K; Feuchtinger A; Slotta-Huspenina J; Becker K; Langer R; Walch A
    PLoS One; 2013; 8(7):e69098. PubMed ID: 23874879
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lack of EGFR mutations benefiting gefitinib treatment in adenocarcinoma of esophagogastric junction.
    Wang WP; Wang KN; Gao Q; Chen LQ
    World J Surg Oncol; 2012 Jan; 10():14. PubMed ID: 22252115
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The histopathologic spectrum of carcinomas involving the gastroesophageal junction in the Chinese.
    Huang Q; Zhang LH
    Int J Surg Pathol; 2007 Jan; 15(1):38-52. PubMed ID: 17172496
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Distribution of p53 mutations in esophageal and gastric carcinomas and the relationship with p53 expression.
    Hanazono K; Natsugoe S; Stein HJ; Aikou T; Hoefler H; Siewert JR
    Oncol Rep; 2006 Apr; 15(4):821-4. PubMed ID: 16525665
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Multidisciplinary Team Conference's Decision on M-Staging in Patients with Gastric- and Gastroesophageal Cancer is not Accurate without Staging Laparoscopy.
    Strandby RB; Svendsen LB; Fallentin E; Egeland C; Achiam MP
    Scand J Surg; 2016 Jun; 105(2):104-8. PubMed ID: 26261200
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Multi-Institutional Study Comparing the Use of the American Joint Committee on Cancer 7th Edition Esophageal
    Adeshuko FA; Squires MH; Poultsides G; Pawlik TM; Weber SM; Schmidt C; Votanopoulos K; Fields RC; Maithel SK; Cardona K
    Am Surg; 2017 Jan; 83(1):82-89. PubMed ID: 28234131
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transcriptomic profiling reveals three molecular phenotypes of adenocarcinoma at the gastroesophageal junction.
    Bornschein J; Wernisch L; Secrier M; Miremadi A; Perner J; MacRae S; O'Donovan M; Newton R; Menon S; Bower L; Eldridge MD; Devonshire G; Cheah C; Turkington R; Hardwick RH; Selgrad M; Venerito M; Malfertheiner P; ; Fitzgerald RC
    Int J Cancer; 2019 Dec; 145(12):3389-3401. PubMed ID: 31050820
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Screening and clinical significance of lymph node metastasis-related genes within esophagogastric junction adenocarcinoma.
    Han R; Chen G; Li M; Peng ZM; Xu L
    Cancer Med; 2021 Aug; 10(15):5088-5100. PubMed ID: 34152098
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Polymeric immunoglobulin receptor-negative tumors represent a more aggressive type of adenocarcinomas of distal esophagus and gastroesophageal junction.
    Gologan A; Acquafondata M; Dhir R; Sepulveda AR
    Arch Pathol Lab Med; 2008 Aug; 132(8):1295-301. PubMed ID: 18684029
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Surveillance and outcomes after curative resection for gastroesophageal adenocarcinoma.
    Jiang DM; Suzuki C; Espin-Garcia O; Lim CH; Ma LX; Sun P; Sim HW; Natori A; Chan BA; Moignard S; Chen EX; Liu G; Swallow CJ; Darling GE; Wong R; Jang RW; Elimova E
    Cancer Med; 2020 May; 9(9):3023-3032. PubMed ID: 32130793
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High-throughput sequencing and copy number variation detection using formalin fixed embedded tissue in metastatic gastric cancer.
    Kim S; Lee J; Hong ME; Do IG; Kang SY; Ha SY; Kim ST; Park SH; Kang WK; Choi MG; Lee JH; Sohn TS; Bae JM; Kim S; Kim DH; Kim KM
    PLoS One; 2014; 9(11):e111693. PubMed ID: 25372287
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic polymorphisms at TIMP3 are associated with survival of adenocarcinoma of the gastroesophageal junction.
    Bashash M; Shah A; Hislop G; Treml M; Bretherick K; Janoo-Gilani R; Leach S; Le N; Bajdik C; Brooks-Wilson A
    PLoS One; 2013; 8(3):e59157. PubMed ID: 23527119
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The mutational landscape of upper gastrointestinal adenocarcinomas- A study of similarities and differences.
    Krishnamurthy K; Urioste SN; Cusnir M; Schwartz M; Alghamdi S; Sriganeshan V; Poppiti R
    Pathol Res Pract; 2022 Apr; 232():153830. PubMed ID: 35240548
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Survey of Her2-neu Expression and its Correlation with Histology of Gastric Carcinoma and Gastroesophageal Junction Adenocarcinoma.
    Madani SH; Rahmati A; Sadeghi E; Khazaei S; Sadeghi M; Payandeh M; Amirifard N
    Asian Pac J Cancer Prev; 2015; 16(17):7755-8. PubMed ID: 26625793
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Circulating Tumor DNA Sequencing Analysis of Gastroesophageal Adenocarcinoma.
    Maron SB; Chase LM; Lomnicki S; Kochanny S; Moore KL; Joshi SS; Landron S; Johnson J; Kiedrowski LA; Nagy RJ; Lanman RB; Kim ST; Lee J; Catenacci DVT
    Clin Cancer Res; 2019 Dec; 25(23):7098-7112. PubMed ID: 31427281
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.